• The Latest Updated Products
  • Home > Product Partnering > The Latest Updated Products
Basic Search Search

Displaying 1 of 2 results per page Prev Next

The Latest Updated Products 게시물 리스트
product_code originator Lab Code or BRAND NAME API Action mechanism Indication Latest development stage Details
 PP140829012365   AstraZeneca (since Jul 2013), Pearl Therapeutics, Inc   Breztri Aerosphere, Trixeo Aerosphere, PT010   budesonide and glycopyrrolate and formoterol fumarate   An inhaled..   Chronic ob..   Approved, Approved    View Details 
 PP180906016669   Minoryx Therapeutics   Nezglyal, MIN-102   leriglitazone   A differen..   X-linked A..   NDA, Approved, Phase II completed    View Details 
 PP181220016907   Ionis Pharmaceuticals, Inc.   IONIS-FB-LRx, RG6299, ASO factor B   sefaxersen   To reduce ..   IgA nephro..   Phase III completed, Phase II    View Details 
 PP200701018208   Eli Lilly and Company   Onswik, LY3209590   insulin efsitora alfa-gobe   Hormone re..   Diabetes t..   Approved    View Details 
 PP210511018642   Chugai Pharmaceutical Co., Ltd.   GYM329, RG6237   emugrobart, emubrobart   An anti-la..   Spinal mus..   Phase III, Dropped, Dropped    View Details 
 PP220406019584   AbbVie Inc.(since Aug 2024), Cerevel Therapeutics   Juvmo, CVL751, PF 6649751, PF-06649751   tavapadon   A novel se..   Early Park..   Approved, Approved    View Details 
 PP220429019689   Amgen Inc. (since Oct 2023), Horizon Therapeutics plc   HZN-4920   dazodalibep   Binding CD..   Focal segm..   Phase II, Phase II, Phase II, Phase III completed    View Details 
 PP220511019717   Incyte Corporation   Atebrioz, INCB00928   zilurgisertib   A potent, ..   Anemia due..   Phase I, Approved    View Details 
 PP220516019738   Ionis Pharmaceuticals, Inc.   ION363   ulefnersen; jacifusen   To reduce ..   Amyotrophi..   Phase III completed    View Details 
 PP230213020363   Astellas Pharma Inc.   ASP3082   setidegrasib   A novel KR..   Pancreatic..   Phase III, Phase III    View Details